Baseline EEG Temporal Dynamics as a Thalamic Filter State Biomarker: A Thalamic Filter Model Account of Ketamine Antidepressant Response Prediction and Depression as Thalamic Over-Filtering

Treatment-resistant depression (TRD) affects approximately 30% of major depressive disorder
(MDD) cases and represents a major unmet clinical need. Ketamine produces rapid antidepressant
effects in TRD, but response is variable and no validated biomarker predicts who will respond.
Multiple independent studies have now shown that baseline EEG features -- particularly vigilance
stage distribution and spectral dynamics -- predict ketamine response, but no unifying mechanistic
account of why baseline brain state should predict response to an NMDA antagonist has been
proposed. We present the Thalamic Filter Model (TFM) as a candidate mechanistic account. The
TFM proposes that depression may represent a state of thalamic over-filtering: chronically
elevated thalamic reticular nucleus (TRN) inhibitory tone raises the thalamic impedance gate
(Phi_th), narrowing conscious bandwidth and producing the cognitive rigidity, rumination, and
affective narrowing characteristic of depression. In this framework, ketamine's rapid
antidepressant effect may reflect indirect TRN disinhibition via glutamatergic synaptic
potentiation, transiently lowering Phi_th and expanding conscious bandwidth. Baseline EEG
temporal dynamics -- specifically lag-1 autocorrelation (AR1) and vigilance stage distribution --
index individual thalamic filter state: patients with higher baseline filter impedance (lower
vigilance, higher AR1) may have more room for ketamine-induced filter opening and thus greater
antidepressant response. We review published evidence from six independent ketamine EEG
biomarker studies (total n > 200) showing that lower baseline vigilance, lower baseline gamma
power, and higher alpha power all predict better ketamine response -- all consistent with the TFM
prediction that higher baseline filter impedance predicts greater response to filter-opening
intervention. We derive three falsifiable predictions distinguishing TFM from alternative accounts
and propose AR1 as a practical, low-cost baseline biomarker for ketamine response prediction.
Keywords: ketamine; treatment-resistant depression; EEG biomarker; thalamic filter; thalamic
reticular nucleus; AR1; autocorrelation; vigilance; antidepressant response prediction; thalamic
impedance